Monoclonal antibody specific for inbred strains
CA 2078725 C · Owner: Kusakabe, Moriaki · Inventors: Kusakabe, Moriaki; Sakakura, Teruyo
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A novel monoclonal antibody of IgG~/ k subclass characterized in, that it recognizes antigens specifically present in mouse inbred strains consisting of DsA/~, CE/J, SM/J, IQI, PL/J SWM/Ms, RIIIS/J, RFM/MsNrs, and C3H and its congenic mouse strains thereof wherein one of said, antigens has a molecular weight of 66,000 and the other has a molecular weight of 68,000 and said antigens are present in the mitochondria of C3H mouse strain. The present invention also provides a hybridoma cell line which produces the above monoclonal antibody a method for identifying the, origin of a cell derived from a mouse and a reagent for identifying, the origin of a cell derived from a mouse.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 21, 1992 and granted July 20, 1999. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 21, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 21, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.